Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality

Abstract

Co-infection is a significant predictor of disease outcome; combined treatment, introduction of an integrated vaccine for all respiratory viruses and development of multi-target rapid diagnostic tests is recommended. Integration of respiratory viruses' co-infections into public health reports could also contribute to the accumulation of evidence.